CN104031120B - 一种治疗癌症的肽变体及其应用 - Google Patents
一种治疗癌症的肽变体及其应用 Download PDFInfo
- Publication number
- CN104031120B CN104031120B CN201410245332.6A CN201410245332A CN104031120B CN 104031120 B CN104031120 B CN 104031120B CN 201410245332 A CN201410245332 A CN 201410245332A CN 104031120 B CN104031120 B CN 104031120B
- Authority
- CN
- China
- Prior art keywords
- peptide
- seq
- cell
- application
- treating cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Description
组织类型 | 细胞系 |
急性早幼粒细胞白血病细胞系 | NB4 |
肝癌 | HepG2 |
胶质母细胞瘤 | U87M6 |
Claims (2)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610002912.1A CN105601714B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002923.XA CN105601715B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002834.5A CN105481948B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002822.2A CN105601710B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002926.3A CN105597078B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002828.XA CN105601713B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201410245332.6A CN104031120B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002930.XA CN105585615B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002817.1A CN105622722B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa3及其应用 |
CN201610002869.9A CN105481949B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002827.5A CN105601712B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002825.6A CN105504016B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002824.1A CN105601711B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa5及其应用 |
CN201610002932.9A CN105504017B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410245332.6A CN104031120B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
Related Child Applications (13)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610002932.9A Division CN105504017B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002930.XA Division CN105585615B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002827.5A Division CN105601712B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002824.1A Division CN105601711B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa5及其应用 |
CN201610002912.1A Division CN105601714B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002825.6A Division CN105504016B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002834.5A Division CN105481948B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002817.1A Division CN105622722B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa3及其应用 |
CN201610002869.9A Division CN105481949B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002828.XA Division CN105601713B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002923.XA Division CN105601715B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002822.2A Division CN105601710B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002926.3A Division CN105597078B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104031120A CN104031120A (zh) | 2014-09-10 |
CN104031120B true CN104031120B (zh) | 2016-08-24 |
Family
ID=51462136
Family Applications (14)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610002822.2A Expired - Fee Related CN105601710B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002834.5A Active CN105481948B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002817.1A Active CN105622722B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa3及其应用 |
CN201410245332.6A Expired - Fee Related CN104031120B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002930.XA Expired - Fee Related CN105585615B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002869.9A Active CN105481949B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002926.3A Active CN105597078B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002912.1A Active CN105601714B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002824.1A Expired - Fee Related CN105601711B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa5及其应用 |
CN201610002923.XA Expired - Fee Related CN105601715B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002827.5A Active CN105601712B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002828.XA Expired - Fee Related CN105601713B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002932.9A Expired - Fee Related CN105504017B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002825.6A Active CN105504016B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610002822.2A Expired - Fee Related CN105601710B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002834.5A Active CN105481948B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002817.1A Active CN105622722B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa3及其应用 |
Family Applications After (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610002930.XA Expired - Fee Related CN105585615B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002869.9A Active CN105481949B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002926.3A Active CN105597078B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002912.1A Active CN105601714B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002824.1A Expired - Fee Related CN105601711B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体xa5及其应用 |
CN201610002923.XA Expired - Fee Related CN105601715B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002827.5A Active CN105601712B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002828.XA Expired - Fee Related CN105601713B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002932.9A Expired - Fee Related CN105504017B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
CN201610002825.6A Active CN105504016B (zh) | 2014-05-29 | 2014-05-29 | 一种治疗癌症的肽变体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (14) | CN105601710B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108276477A (zh) * | 2018-03-29 | 2018-07-13 | 张建华 | 一种治疗癌症的合成多肽及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2146262C1 (ru) * | 1993-06-30 | 2000-03-10 | Фармация Энд Апджон С.П.А. | Пептиды, способ их получения, фармацевтическая композиция и способ ее получения |
US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
FR2960542B1 (fr) * | 2010-05-27 | 2012-08-17 | Esther Suzy Arlette Fellous | Peptide en tant que medicament, en particulier pour le traitement du cancer |
CN103288926B (zh) * | 2013-05-30 | 2014-07-09 | 王朝霞 | 一种微管蛋白聚合剂多肽及其应用 |
CN103265621B (zh) * | 2013-05-30 | 2014-06-25 | 北京新领先医药科技发展有限公司 | 一种微管蛋白解聚剂多肽及其应用 |
-
2014
- 2014-05-29 CN CN201610002822.2A patent/CN105601710B/zh not_active Expired - Fee Related
- 2014-05-29 CN CN201610002834.5A patent/CN105481948B/zh active Active
- 2014-05-29 CN CN201610002817.1A patent/CN105622722B/zh active Active
- 2014-05-29 CN CN201410245332.6A patent/CN104031120B/zh not_active Expired - Fee Related
- 2014-05-29 CN CN201610002930.XA patent/CN105585615B/zh not_active Expired - Fee Related
- 2014-05-29 CN CN201610002869.9A patent/CN105481949B/zh active Active
- 2014-05-29 CN CN201610002926.3A patent/CN105597078B/zh active Active
- 2014-05-29 CN CN201610002912.1A patent/CN105601714B/zh active Active
- 2014-05-29 CN CN201610002824.1A patent/CN105601711B/zh not_active Expired - Fee Related
- 2014-05-29 CN CN201610002923.XA patent/CN105601715B/zh not_active Expired - Fee Related
- 2014-05-29 CN CN201610002827.5A patent/CN105601712B/zh active Active
- 2014-05-29 CN CN201610002828.XA patent/CN105601713B/zh not_active Expired - Fee Related
- 2014-05-29 CN CN201610002932.9A patent/CN105504017B/zh not_active Expired - Fee Related
- 2014-05-29 CN CN201610002825.6A patent/CN105504016B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105504016A (zh) | 2016-04-20 |
CN105601711A (zh) | 2016-05-25 |
CN105601714A (zh) | 2016-05-25 |
CN105481949B (zh) | 2019-11-12 |
CN105601712A (zh) | 2016-05-25 |
CN105601710A (zh) | 2016-05-25 |
CN105585615B (zh) | 2019-11-15 |
CN105601711B (zh) | 2019-11-05 |
CN105585615A (zh) | 2016-05-18 |
CN105622722A (zh) | 2016-06-01 |
CN105601713A (zh) | 2016-05-25 |
CN105481948A (zh) | 2016-04-13 |
CN105504017B (zh) | 2019-05-03 |
CN105504017A (zh) | 2016-04-20 |
CN105601715B (zh) | 2019-10-01 |
CN105601715A (zh) | 2016-05-25 |
CN105601713B (zh) | 2019-10-22 |
CN105481949A (zh) | 2016-04-13 |
CN105601710B (zh) | 2019-10-15 |
CN105601714B (zh) | 2019-09-13 |
CN105597078B (zh) | 2019-01-25 |
CN105597078A (zh) | 2016-05-25 |
CN105504016B (zh) | 2019-01-01 |
CN105622722B (zh) | 2019-12-24 |
CN104031120A (zh) | 2014-09-10 |
CN105601712B (zh) | 2019-10-11 |
CN105481948B (zh) | 2019-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103204907B (zh) | 孔鳐软骨多肽类血管生成抑制因子及其制备方法和用途 | |
CN105524142B (zh) | 一种十六肽qtddnhsnvlwagfsr及其应用 | |
CN104031120B (zh) | 一种治疗癌症的肽变体及其应用 | |
US8076284B2 (en) | Analogues of antimicrobial and anticancer peptide synthesized and produced from Gaegurin 5 | |
TWI517855B (zh) | 用於治療肺癌之牛樟芝萃取物及其製備方法 | |
US10668112B2 (en) | Formulation for targeting cancer in humans and canines | |
CN110117324A (zh) | 一种抗肿瘤活性多肽及其用途 | |
Febriyanti et al. | The Effectiveness of Mirabilis jalapa Leaf Methanol Extract's Concentration on the Growth of Streptococcus pyogenes. | |
US10668113B2 (en) | Formulation for targeting cancer in humans and canines using venom | |
CN108778302A (zh) | 制备昭和草提取物的方法,由此制备的提取物以及所述提取物的用途 | |
CN104987377A (zh) | 天然抗感染抗肿瘤双功能多肽ecct及其基因与应用 | |
CN106589095A (zh) | 一种抗癌活性肽变体及其应用 | |
CN106589096A (zh) | 一种抗癌活性肽变体及其应用 | |
Ruiz et al. | Antibacterial activity of the enniatins A, A1, B, B1 produced by fusarium tricinctum in liquid culture, and cytotoxicity effects on Caco-2 cells | |
WO2012130999A1 (fr) | Peptides isolés et purifiés à partir de testicules de roussettes | |
US20150209398A1 (en) | Melaleuca quinquenervia extracts and uses of the same | |
CN105037495A (zh) | 一种具有抗乳腺癌活性的寡肽 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Fengyu Inventor after: Wang Linqing Inventor after: Wang Haili Inventor before: Zhu Lingwei |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160714 Address after: 450002 Hongqi Road 26, Jinshui District, Henan, Zhengzhou Applicant after: Wang Fengyu Address before: 100073 Beijing city of Fengtai District in the Pacific east building 18 room 307 Applicant before: Zhu Lingwei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20170529 |
|
CF01 | Termination of patent right due to non-payment of annual fee |